Atherosclerosis and Hyperlipidemia Research

Atherosclerosis is a disorder of the arteries characterized by the formation of hard structures called atherosclerotic plaques. It is a prevalent disorder, accounting for one third of all deaths in North America.

Atherosclerosis and Hyperlipidemia Research Products Targets

Products for Atherosclerosis and Hyperlipidemia Research

Cat.No. Product Name Information/Activity
BCC5019 Benazepril HCl Benazepril hydrochloride, an angiotensin converting enzyme inhibitor, which is a medication used to treat high blood pressure.
BCC2140 Captopril Captopril (SQ-14534) is a potent, competitive inhibitor of angiotensin-converting enzyme (ACE).
BCC5015 Moexipril HCl Moexipril hydrochloride is a potent orally active non-sulfhydryl angiotensin converting enzyme(ACE) inhibitor, which is used for the treatment of hypertension and congestive heart failure.
BCC3586 Perindopril Erbumine Perindopril erbumine (Perindopril tert-butylamine salt) is a potent ACE inhibitor of which is used to treat high blood pressure, heart failure or stable coronary artery disease.
BCC2349 Spinorphin Enkephalin-degrading and ACE inhibitor
BCC1004 Angiotensin I (human, mouse, rat) Angiotensin 1 (Human) is the precursor to the vasoconstrictor peptide angiotensin II, cleaved by the angiotensin-converting enzyme (ACE).
BCC5807 Hemopressin (rat) 568588-77-2
BCC5018 Aliskiren Hemifumarate Aliskiren hemifumarate(CGP 60536 hemifumarate) is a direct renin inhibitor with IC50 of 1.5 nM.
BCC3944 A 205804 A-205804 is an orally bioavailable, potent and selective lead inhibitor of E-selectin and ICAM-1 expression, with an IC50 of 20 nM and 25 nM for E-selectin and ICAM-1, respectively. A-205804 can be used in the research of chronic inflammatory diseases.
BCC3946 A 286982 Potent inhibitor of the LFA-1/ICAM-1 interaction